The current and emerging role of cardiovascular magnetic resonance imaging in hypertrophic cardiomyopathy

Journal of Cardiovascular Translational Research

Volumn 2, Issue 4, 2009, Pages 415-425

  Maron, Martin S ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

Cardiovascular Magnetic Resonance; Hypertrophic Cardiomyopathy

Indexed keywords

GADOLINIUM; CONTRAST MEDIUM;

CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE ISCHEMIA; HEART PAPILLARY MUSCLE; HEART RIGHT VENTRICLE HYPERTROPHY; HEART SURGERY; HEART VENTRICLE TACHYCARDIA; HOLTER MONITORING; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MUSCLE RESECTION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIOCARDIOGRAPHY; REVIEW; THREE DIMENSIONAL IMAGING; CARDIOMYOPATHY, HYPERTROPHIC; DIAGNOSTIC USE; FIBROSIS; HEART MUSCLE; HEART VENTRICLE FUNCTION; HEMODYNAMICS; PATHOLOGY; PATHOPHYSIOLOGY; PHENOTYPE; PREDICTIVE VALUE; PROGNOSIS; SEVERITY OF ILLNESS INDEX;

CARDIOMYOPATHY, HYPERTROPHIC; CONTRAST MEDIA; FIBROSIS; GADOLINIUM; HEMODYNAMICS; HUMANS; MAGNETIC RESONANCE IMAGING; MYOCARDIUM; PAPILLARY MUSCLES; PHENOTYPE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SEVERITY OF ILLNESS INDEX; VENTRICULAR FUNCTION;

EID: 75949083971     PISSN: 19375387     EISSN: 19375395     Source Type: Journal    
DOI: 10.1007/s12265-009-9136-3     Document Type: Review

References (42)

1. BJ Maron 2002 Hypertrophic cardiomyopathy: A systematic review JAMA 287 10 1308 1320 10.1001/jama.287.10.1308 11886323
2. BJ Maron WJ McKenna GK Danielson LJ Kappenberger HJ Kuhn CE Seidman, et al. 2003 American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines Journal of the American College of Cardiology 42 9 1687 1713 10.1016/S0735-1097(03)00941-0 14607462 (Pubitemid 37383745)
3. ED Wigle H Rakowski BP Kimball WG Williams 1995 Hypertrophic cardiomyopathy. Clinical spectrum and treatment Circulation 92 7 1680 1692 1:STN:280:DyaK2MvgtFeiug%3D%3D 7671349
4. LM Shapiro WJ McKenna 1983 Distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy: A two-dimensional echocardiographic study Journal of the American College of Cardiology 2 3 437 444 1:STN:280: DyaL3s3ms1Gkuw%3D%3D 6683731
5. ED Wigle Z Sasson MA Henderson TD Ruddy J Fulop H Rakowski, et al. 1985 Hypertrophic cardiomyopathy. The importance of the site and the extent of hypertrophy. A review Progress in Cardiovascular Diseases 28 1 1 83 10.1016/0033-0620(85)90024-6 1:STN:280:DyaL2M3ktlCmsg%3D%3D 3160067 (Pubitemid 15237515)
6. RM Judd CH Lugo-Olivieri M Arai T Kondo P Croisille JA Lima, et al. 1995 Physiological basis of myocardial contrast enhancement in fast magnetic resonance images of 2-day-old reperfused canine infarcts Circulation 92 7 1902 1910 1:STN:280:DyaK2MvgtFentQ%3D%3D 7671375
7. RJ Kim DS Fieno TB Parrish K Harris EL Chen O Simonetti, et al. 1999 Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function Circulation 100 19 1992 2002 1:STN:280: DC%2BD3c%2FivVensg%3D%3D 10556226
8. RJ Kim RM Judd 2003 Gadolinium-enhanced magnetic resonance imaging in hypertrophic cardiomyopathy: In vivo imaging of the pathologic substrate for premature cardiac death? Journal of the American College of Cardiology 41 9 1568 1572 10.1016/S0735-1097(03)00190-6 12742299 (Pubitemid 36543377)
9. RJ Kim E Wu A Rafael EL Chen MA Parker O Simonetti, et al. 2000 The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction New England Journal of Medicine 343 20 1445 1453 10.1056/NEJM200011163432003 1:STN:280:DC%2BD3M%2FisFWnsw%3D%3D 11078769 (Pubitemid 30832880)
10. JA Lima MY Desai 2004 Cardiovascular magnetic resonance imaging: Current and emerging applications Journal of the American College of Cardiology 44 6 1164 1171 10.1016/j.jacc.2004.06.033 15364314 (Pubitemid 39208868)
11. JC Moon NG Fisher WJ McKenna DJ Pennell 2004 Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography Heart 90 6 645 649 10.1136/hrt.2003.014969 1:STN:280:DC%2BD2c3kslSisg%3D%3D 15145868
12. JC Moon WJ McKenna JA McCrohon PM Elliott GC Smith DJ Pennell 2003 Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance Journal of the American College of Cardiology 41 9 1561 1567 10.1016/S0735-1097(03)00189-X 12742298 (Pubitemid 36543376)
13. DJ Pennell 2003 Cardiovascular magnetic resonance: Twenty-first century solutions in cardiology Clinical Medicine 3 3 273 278 12848266
14. C Rickers NM Wilke M Jerosch-Herold SA Casey P Panse N Panse, et al. 2005 Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy Circulation 112 6 855 861 10.1161/CIRCULATIONAHA.104.507723 16087809 (Pubitemid 41170072)
15. CE Rochitte EM Tassi AA Shiozaki 2006 The emerging role of MRI in the diagnosis and management of cardiomyopathies Current Cardiology Reports 8 1 44 52 10.1007/s11886-006-0010-5 16507236
16. Maron MS AE, H. C., Buros, J., Gibson, C. M., Hanna, C., Lesser, J. R., Udelson, J. E., et al. (2008). Clinical profile and significance of delayed enhancement in hypertrophic cardiomyopathy. Circulation: Heart Failure, 2008(1), 184-191.
17. MS Maron BJ Maron C Harrigan J Buros CM Gibson I Olivotto, et al. 2009 Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance Journal of the American College of Cardiology 54 3 220 228 10.1016/j.jacc.2009.05.006 19589434
18. CJ Harrigan E Appelbaum BJ Maron JL Buros CM Gibson JR Lesser, et al. 2008 Significance of papillary muscle abnormalities identified by cardiovascular magnetic resonance in hypertrophic cardiomyopathy American Journal of Cardiology 101 5 668 673 10.1016/j.amjcard.2007.10.032 18308018 (Pubitemid 351635561)
19. KM Harris P Spirito MS Maron AG Zenovich F Formisano JR Lesser, et al. 2006 Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy Circulation 114 3 216 225 10.1161/CIRCULATIONAHA.105.583500 16831987 (Pubitemid 44297115)
20. JC Moon E Reed MN Sheppard AG Elkington SY Ho M Burke, et al. 2004 The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy Journal of the American College of Cardiology 43 12 2260 2264 10.1016/j.jacc.2004.03.035 15193690 (Pubitemid 38757595)
21. AS Adabag BJ Maron E Appelbaum CJ Harrigan JL Buros CM Gibson, et al. 2008 Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance Journal of the American College of Cardiology 51 14 1369 1374 10.1016/j.jacc.2007.11.071 18387438
22. L Choudhury H Mahrholdt A Wagner KM Choi MD Elliott FJ Klocke, et al. 2002 Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy Journal of the American College of Cardiology 40 12 2156 2164 10.1016/S0735-1097(02)02602-5 12505229 (Pubitemid 36005903)
23. CM Kramer 2006 The expanding prognostic role of late gadolinium enhanced cardiac magnetic resonance Journal of the American College of Cardiology 48 10 1986 1987 10.1016/j.jacc.2006.08.018 17112988 (Pubitemid 44738447)
24. F Grothues GC Smith JC Moon NG Bellenger P Collins HU Klein, et al. 2002 Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy American Journal of Cardiology 90 1 29 34 10.1016/S0002-9149(02)02381-0 12088775 (Pubitemid 34671198)
25. MS Maron JJ Finley JM Bos TH Hauser WJ Manning TS Haas, et al. 2008 Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy Circulation 118 15 1541 1549 10.1161/CIRCULATIONAHA.108.781401 18809796
26. MS Maron TH Hauser E Dubrow TA Horst KV Kissinger JE Udelson, et al. 2007 Right ventricular involvement in hypertrophic cardiomyopathy American Journal of Cardiology 100 8 1293 1298 10.1016/j.amjcard.2007.05.061 17920373 (Pubitemid 47500158)
27. BJ Maron MS Maron JR Lesser RG Hauser TS Haas CJ Harrigan, et al. 2008 Sudden cardiac arrest in hypertrophic cardiomyopathy in the absence of conventional criteria for high risk status American Journal of Cardiology 101 4 544 547 18312775
28. DH Kwon RM Setser M Thamilarasan ZV Popovic NG Smedira P Schoenhagen 2008 Abnormal papillary muscle morphology is independently associated with increased left ventricular outflow tract obstruction in hypertrophic cardiomyopathy Heart (British Cardiac Society) 94 10 1295 1301 1:STN:280:DC%2BD1cnhtFegsg%3D%3D
29. I Olivotto MS Maron C Autore JR Lesser L Rega G Casolo, et al. 2008 Assessment and significance of left ventricular mass by cardiovascular magnetic resonance in hypertrophic cardiomyopathy Journal of the American College of Cardiology 52 7 559 566 10.1016/j.jacc.2008.04.047 18687251
30. T Germans AA Wilde PA Dijkmans W Chai O Kamp YM Pinto, et al. 2006 Structural abnormalities of the inferoseptal left ventricular wall detected by cardiac magnetic resonance imaging in carriers of hypertrophic cardiomyopathy mutations Journal of the American College of Cardiology 48 12 2518 2523 10.1016/j.jacc.2006.08.036 17174192 (Pubitemid 44881223)
31. B Strijack V Ariyarajah R Soni DS Jassal CR Greenberg R McGregor, et al. 2008 Late gadolinium enhancement cardiovascular magnetic resonance in genotyped hypertrophic cardiomyopathy with normal phenotype Journal of Cardiovascular Magnetic Resonance 10 1 58 10.1186/1532-429X-10-58 19087273
32. P Camici G Chiriatti R Lorenzoni RC Bellina R Gistri G Italiani, et al. 1991 Coronary vasodilation is impaired in both hypertrophied and nonhypertrophied myocardium of patients with hypertrophic cardiomyopathy: a study with nitrogen-13 ammonia and positron emission tomography Journal of the American College of Cardiology 17 4 879 886 1:STN:280:DyaK3M7lsVGqtQ%3D%3D 1999624
33. F Cecchi I Olivotto R Gistri R Lorenzoni G Chiriatti PG Camici 2003 Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy New England Journal of Medicine 349 11 1027 1035 10.1056/NEJMoa025050 1:CAS:528:DC%2BD3sXntlagtbc%3D 12968086 (Pubitemid 37087617)
34. I Olivotto F Cecchi R Gistri R Lorenzoni G Chiriatti F Girolami, et al. 2006 Relevance of coronary microvascular flow impairment to long-term remodeling and systolic dysfunction in hypertrophic cardiomyopathy Journal of the American College of Cardiology 47 5 1043 1048 10.1016/j.jacc.2005.10.050 16516091 (Pubitemid 43312768)
35. SE Petersen M Jerosch-Herold LE Hudsmith MD Robson JM Francis HA Doll, et al. 2007 Evidence for microvascular dysfunction in hypertrophic cardiomyopathy: New insights from multiparametric magnetic resonance imaging Circulation 115 18 2418 2425 10.1161/CIRCULATIONAHA.106.657023 17452610 (Pubitemid 46717964)
36. B Sotgia R Sciagra I Olivotto G Casolo L Rega I Betti, et al. 2008 Spatial relationship between coronary microvascular dysfunction and delayed contrast enhancement in patients with hypertrophic cardiomyopathy Journal of Nuclear Medicine 49 7 1090 1096 10.2967/jnumed.107.050138 18552138
37. DH Kwon NG Smedira ER Rodriguez C Tan R Setser M Thamilarasan, et al. 2009 Cardiac magnetic resonance detection of myocardial scarring in hypertrophic cardiomyopathy: Correlation with histopathology and prevalence of ventricular tachycardia Journal of the American College of Cardiology 54 3 242 249 10.1016/j.jacc.2009.04.026 19589437
38. DS Fieno RJ Kim EL Chen JW Lomasney FJ Klocke RM Judd 2000 Contrast-enhanced magnetic resonance imaging of myocardium at risk: Distinction between reversible and irreversible injury throughout infarct healing Journal of the American College of Cardiology 36 6 1985 1991 10.1016/S0735-1097(00)00958-X 1:STN:280:DC%2BD3M%2FkvFajtA%3D%3D 11092675 (Pubitemid 30844116)
39. OP Simonetti RJ Kim DS Fieno HB Hillenbrand E Wu JM Bundy, et al. 2001 An improved MR imaging technique for the visualization of myocardial infarction Radiology 218 1 215 223 1:STN:280:DC%2BD3MzitFCntg%3D%3D 11152805
40. JM Wilson RP Villareal R Hariharan A Massumi R Muthupillai SD Flamm 2002 Magnetic resonance imaging of myocardial fibrosis in hypertrophic cardiomyopathy Texas Heart Institute Journal 29 3 176 180 12224720
41. DH Kwon RM Setser ZB Popovic M Thamilarasan S Sola P Schoenhagen, et al. 2008 Association of myocardial fibrosis, electrocardiography and ventricular tachyarrhythmia in hypertrophic cardiomyopathy: A delayed contrast enhanced MRI study The International Journal of Cardiovascular Imaging 24 6 617 625 10.1007/s10554-008-9292-6 18204915
42. US Valeti RA Nishimura DR Holmes PA Araoz JF Glockner JF Breen, et al. 2007 Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy Journal of the American College of Cardiology 49 3 350 357 10.1016/j.jacc.2006.08.055 17239717 (Pubitemid 46097376)